Recorded fact · drug.label_indication
drug.label_indication for ruxolitinib-phosphate|atopic-dermatitis
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact 75ff0191 resolves to.
The record
| Fact id | 75ff0191435ce2d3f5713b74 |
|---|---|
| Entity | drug: ruxolitinib-phosphate|atopic-dermatitis |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260630 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or w
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 8037ac30e4b70e4a70cf7c048ac2c52cc333b6dc5652cd7aaa1f3165591e01e9.
The value
{
"ingredient": "Ruxolitinib Phosphate",
"conditionId": "atopic-dermatitis",
"conditionName": "Atopic dermatitis",
"matchedAlias": "atopic dermatitis",
"context": "indication",
"brand": "OPZELURA",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "24da5509-6631-4795-9d42-273faecd08e7",
"labelEffectiveTime": "20260630",
"labelsRead": 2,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 569fc9c6d3fafde0a208ac00dda0d9d4dfa204684e65dbb578506ffec21afcc4.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.